N/A N=18 Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea
Polycystic Ovary Syndrome · Obstructive Sleep Apnea
Primary: Estrogen Levels — 73.3; 69.9; 61.0 pg/ml
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=54 Hookah Additive Research to Inform Product Standards
Tobacco-Related Carcinoma
Primary: Change in Exhaled Breath Carbon Monoxide (CO) — 80.1; 40.8; 62.5; 45.5 ppm
Phase 2 N=65 A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum
Pseudoxanthoma Elasticum
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs) in Participants Receiving DS-1211b — 8; 7; 6; 6 Participants
Phase 1 N=3 A BCT Intervention for Physical Activity Among Individuals on Statins
Insufficient Physical Activity
Primary: Number of Participants Who Achieved a 2,000 Step/Day Increase Between run-in and Follow-up — 7 Participants
N/A N=22 Digital Health for Medication Adherence Among African Americans With Hypertension
Hypertension
Primary: Wilson Self Report Medication Adherence Scale — 91.86 units on a scale
Phase 2 N=15 ANC-501 in the Treatment of Adults With Major Depressive Disorder
Major Depressive Disorder
Primary: Mean Change From Baseline (Day 1) to Day 56 in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score. — -17.5 score on a scale
N/A N=77 Phone Coaching for Weight Loss Maintenance
Obesity · Weight Loss
Primary: Percent Change in Body Weight From Baseline to Month 12 — 5.18; 5.71 percent change
Phase 3 N=784 A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease
Neuropsychiatric Symptoms Related to Neurodegenerative Disease
Primary: Treatment-emergent Adverse Events (TEAEs) — 115; 119 Participants
Phase 2 N=20 Peripheral Oxytocin and Touch
Healthy Adults
Primary: Change in Mean Pleasantness Rating of Gentle Brushing — -8.7; -14.1 score on a scale
Phase 2 N=277 A Study of JZP150 in Adults With Posttraumatic Stress Disorder
Post Traumatic Stress Disorder
Primary: Mean Change From Baseline to Week 12 in Clinician Administered Posttraumatic Stress Disorder (PTSD) Scale (CAPS-5) Total Symptom Severity Score — -17.0; -17.8; -17.6…
N/A N=62 PHIL in the Treatment of Intracranial dAVF.
Arteriovenous Dural Fistula
Primary: Subjects With Neurological Death or Ipsilateral Stroke — 0 Participants
N/A N=17,033 PrOVE QUERI Project #1
Prevention and Control
Primary: Odds Ratio of the Interaction Between Lung Cancer Risk and Implementation Arm — 1.03; 1.53 odds ratio — p=0.081
N/A N=40 Ultrasound to Verify Lung-isolation During Single-lung Ventilation
Thoracic Diseases
Primary: The Accuracy of Using Ultrasound to Assess Lung Isolation by Visualizing Lung Movement or Lack Thereof of Both the Operative and Non-operative Lung Fields. — 97; 65; 67…
Phase 2 N=25 A Gene Transfer Study for Hemophilia A
Hemophilia A
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs) — 2; 3; 9; 11 Participants
N/A N=11 Battlefield Auricular Acupressure (BAApress) Feasibility Study
Pain
Primary: Patient Reported Pain and General Activity Scores (Visual Analogue Scale) — 65 mm